Until now, the sole evidence for how many reads are required for successful therapy with c-Met inhibitors was a case report about the highest sensitivity of the OFA, which detected 46 reads for METex14 in an NSCLC patient without known actionable variants, who was previously treated with various chemotherapeutic agents without positive effects. This evidence concerns the gene MET and non-small cell lung carcinoma.